Clinical Trial Update: A Study on the Efficacy of Agomelatine Combined With Antipsychotics to Treat Negative Symptoms in Schizophrenia [Phase 4]

View source ↗

Summary

A Phase 4 study evaluating agomelatine in combination with antipsychotics for negative symptoms in schizophrenia; current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Negative Symptoms in Schizophrenia
• Schizophrenia

Drugs mentioned

• Agomelatine (agomelatine)

Snippet

Sponsor: Shanghai Mental Health Center | Conditions: Schizophrenia, Negative Symptoms in Schizophrenia | Phase 4 | Status: UNKNOWN